कृपया अन्य खोज का प्रयास करें
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins. The company’s patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company’s products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was incorporated in 2011 and is headquartered in Marietta, Georgia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
M. Kathleen Behrens Wilsey | 68 | 2019 | Independent Chairman of the Board |
Robert Guldberg | - | - | Member of Regenerative Medicine Scientific Advisory Board |
Anthony Atala | 65 | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
Philip G. Conaghan | - | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
Vibeke S. Strand | - | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
Regis J. O’Keefe | - | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
Asger Bihlet | - | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
Michael J. Giuliani | 69 | 2020 | Independent Director |
Eric W. Carson | - | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
Kris John Alden | - | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
Cato T. Laurencin | 64 | 2020 | Independent Director |
Phyllis Irene Gardner | 72 | 2021 | Independent Director |
Olga Kubassova | - | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
Scott Rodeo | - | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
Constance Chu | - | 2022 | Member of Regenerative Medicine Scientific Advisory Board |
James R. Andrews | 80 | - | Member of Medical Advisory Board |
Glenn Gaston | - | - | Member of Medical Advisory Board |
Thomas Zdeblick | - | - | Member of Medical Advisory Board |
K. Todd Newton | 60 | 2019 | Independent Director |
William A. Hawkins | 69 | 2020 | Independent Preferred Director |
Martin Paul Sutter | 68 | 2020 | Independent Preferred Director |
James L. Bierman | 70 | 2019 | Independent Director |
Dorothy E. Puhy | 72 | 2024 | Independent Director |
Tiffany P. Olson | 65 | 2024 | Independent Director |
Joseph H. Capper | 60 | 2023 | CEO & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है